Nasdaq Gives Tripos Until May 3 to Regain Compliance for Share, Market Cap, and Equity Deficiency | GenomeWeb
NEW YORK (GenomeWeb News) — The Nasdaq exchange has notified Tripos that its stock faces delisting because the company failed to maintain a $10-million minimum equity requirement in 2006, Tripos said yesterday.
The notice comes around three months after the Nasdaq notified Tripos it faced delisting for failing to maintain a minimum bid price of $1 per share, and for failing to maintain the minimum market cap of $5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.